NRT Smoking Cessation Aids in Switzerland

NRT Smoking Cessation Aids in Switzerland

  • October 2017 •
  • 18 pages •
  • Report ID: 149236
Smoking prevalence in Switzerland is on the decline, but only marginally. In 2017, 25% of the Swiss population smoked, down from 26% in 2013. 29% of men smoked, and 22% of women. The smoking ban in public places and stricter tobacco legislation affected smoking prevalence. The anti-smoking campaigns run by the government and the medical establishment, as well as lobby groups, continue to raise awareness of the health risks involved in smoking, and also create a social stigma. Consequently, this...

Euromonitor International’s NRT Smoking Cessation Aids in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage:
NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=Switzerland Industry=OTC ParentIndustry=LifeSciences Date=201710 Topic=Demand Publisher=EuromonitorInternational Price=1000